BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma

20260 citationsJournal Articlegreen Open Access

Authors

Justin Ferdinandus · University of Cologne

Horst Müller · University of Cologne

Janina Jablonski · University of Cologne

Andrea Kerkhoff · University Hospital Münster

Sebastian Scholl · Jena University Hospital

Yon-Dschun Ko · Johanniter-Krankenhaus Bonn

Max S. Topp ·

Abstract

This secondary analysis of the GHSG HD21 randomized clinical trial evaluates the tolerability and impact of BrECADD vs escalated BEACOPP on health-related quality of life for patients with Hodgkin lymphoma.

Topics & Keywords

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research CNS Lymphoma Diagnosis and Treatment

Publication Details

Published in: JAMA Oncology

DOI: 10.1001/jamaoncol.2025.6327

Field-Weighted Citation Impact: 0.00

Command Palette

BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma

Authors

Abstract

Topics & Keywords

Publication Details